SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-171149
Filing Date
2021-05-25
Accepted
2021-05-24 17:44:02
Documents
18
Period of Report
2021-05-24
Items
Item 2.04: Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d189409d8k.htm   iXBRL 8-K 36098
2 EX-99.1 d189409dex991.htm EX-99.1 14668
3 EX-99.2 d189409dex992.htm EX-99.2 13494
4 EX-99.3 d189409dex993.htm EX-99.3 26263
8 GRAPHIC g189409g0524205019997.jpg GRAPHIC 2724
9 GRAPHIC g189409g0524205323738.jpg GRAPHIC 2724
10 GRAPHIC g189409g96g40.jpg GRAPHIC 3750
  Complete submission text file 0001193125-21-171149.txt   256489

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA bhc-20210524.xsd EX-101.SCH 2733
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE bhc-20210524_lab.xml EX-101.LAB 19579
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bhc-20210524_pre.xml EX-101.PRE 12276
11 EXTRACTED XBRL INSTANCE DOCUMENT d189409d8k_htm.xml XML 3961
Mailing Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8
Business Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8 514-744-6792
Bausch Health Companies Inc. (Filer) CIK: 0000885590 (see all company filings)

IRS No.: 000000000 | State of Incorp.: NJ | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-14956 | Film No.: 21956475
SIC: 2834 Pharmaceutical Preparations